Immune Response to Extracellular Vesicles from Human Islets of Langerhans in Patients with Type 1 Diabetes

39Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

The autoimmune response that characterizes type 1 diabetes (T1D) has no clear cause. Extracellular vesicles (EVs) play an important role in triggering the immune response in other contexts. Here, we propose a model by which EVs isolated from human islets stimulate proinflammatory immune responses and lead to peripheral blood mononuclear cell (PBMC) activation. We show that human islet EVs are internalized by monocytes and B cells and lead to an increase in T-helper 1, 2, and 17 cytokine expression, as well as T and B cell proliferation. Importantly, we demonstrate memory T and B cell activation by EVs selectively in PBMCs of patients with T1D. Additionally, human islet EVs induce an increase in antibodies against glutamic acid decarboxylase 65 (GAD65) in T1D PBMCs. Furthermore, pretreatment of T1D PBMCs with ibrutinib, an inhibitor of Bruton tyrosine kinase, dampens EV-induced memory B cell activation and GAD65 antibody production. Collectively, our findings indicate a role for human islet EVs in mediating activation of B and T cells and GAD65 autoantibody production.

Cite

CITATION STYLE

APA

Rutman, A. K., Negi, S., Gasparrini, M., Hasilo, C. P., Tchervenkov, J., & Paraskevas, S. (2018). Immune Response to Extracellular Vesicles from Human Islets of Langerhans in Patients with Type 1 Diabetes. Endocrinology, 159(11), 3834–3847. https://doi.org/10.1210/en.2018-00649

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free